Brazil vs Trinidad and Tobago: Tuberculosis treatment success rate by type
Brazil
65
in 2023
Trinidad and Tobago
66
in 2023
Brazil rank
165th
Trinidad and Tobago rank
164th
Tuberculosis treatment success rate by type over time
- Brazil
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 66 against 65 in Brazil, a difference of 1.
The two have swapped places 6 times across 28 shared years of data; in 1995 it was Trinidad and Tobago ahead.
Brazil ranks 165th and Trinidad and Tobago ranks 164th of 194 countries.
Across the 4 decades both report, Brazil averaged higher in 2 and Trinidad and Tobago in 2.
Head to head by decade
| Decade | Brazil | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 36.4 | 69.4 | 33 | Trinidad and Tobago |
| 2000s | 69.67 | 64.89 | 4.78 | Brazil |
| 2010s | 71.4 | 65.9 | 5.5 | Brazil |
| 2020s | 65.75 | 69.75 | 4 | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, Brazil or Trinidad and Tobago?
- Trinidad and Tobago, at 66 against 65 in Brazil as of 2023.
- What is the difference in tuberculosis treatment success rate by type between Brazil and Trinidad and Tobago?
- 1, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Brazil and Trinidad and Tobago?
- 28 years are reported by both, from 1995 to 2023.
- How do Brazil and Trinidad and Tobago rank globally for tuberculosis treatment success rate by type?
- Brazil ranks 165th and Trinidad and Tobago ranks 164th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.